Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genes.

Filiaciones

Novoa-Jáuregui S:

Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain

Huber S:

MLL Munich Leukemia Laboratory, Munich, Germany

Gabarrós-Subirà M:

Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Chen-Liang TH:

Department of Hematology, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Murcia, Spain

Torres-Esquius S:

Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Carrillo-Tornel S:

Department of Hematology, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Murcia, Spain

Santiago M:

Instituto de Investigación. Department of Hematology, Hospital Universitario y Politécnico La Fe, Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia. Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain

Bernal Del Castillo T:

Department of Hematology, Hospital Universitario Central de Asturias Instituto de Investigación del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, (IUOPA), Oviedo, Spain

Martín-Castillo I:

Department of Hematology, Hospital Clínico Universitario de Valencia, INCLIVA Research Institute, University of Valencia, Valencia, Spain

Hernandez FM:

Department of Hematology, Hospital Virgen de las Nieves, Granada, Spain

Del Rey M:

Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain

Liquori A:

Instituto de Investigación. Department of Hematology, Hospital Universitario y Politécnico La Fe, Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia. Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain

Tormo M:

Department of Hematology, Hospital Clínico Universitario de Valencia, INCLIVA Research Institute, University of Valencia, Valencia, Spain

Cervera J:

Instituto de Investigación. Department of Hematology, Hospital Universitario y Politécnico La Fe, Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia. Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain

Bosch F:

Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain

Valcárcel D:

Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain

Haferlach C:

MLL Munich Leukemia Laboratory, Munich, Germany

Díez-Campelo M:

Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain

Montoro MJ:

Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain

Haferlach T:

MLL Munich Leukemia Laboratory, Munich, Germany

Jerez A:

Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain